Abstract:Glioblastoma multiforme (GBM) is a very aggressive and lethal primary brain cancer in adults. The multifaceted nature of GBM pathogenesis, rising from complex interactions between cells and the tumor microenvironment (TME), has posed great treatment challenges. Despite significant scientific efforts, the prognosis for GBM remains very poor, even after intensive treatment with surgery, radiation, and chemotherapy. Efficient GBM management still requires the invention of innovative treatment strategies. There is a strong necessity to complete cancer in vitro studies and in vivo studies to properly evaluate the mechanisms of tumor progression within the complex TME. In recent years, the animal models used to study GBM tumors have evolved, achieving highly invasive GBM models able to provide key information on the molecular mechanisms of GBM onset. At present, the most commonly used animal models in GBM research are represented by mammalian models, such as mouse and canine ones. However, the latter present several limitations, such as high cost and time-consuming management, making them inappropriate for large-scale anticancer drug evaluation. In recent years, the zebrafish (Danio rerio) model has emerged as a valuable tool for studying GBM. It has shown great promise in preclinical studies due to numerous advantages, such as its small size, its ability to generate a large cohort of genetically identical offspring, and its rapid development, permitting more time- and cost-effective management and high-throughput drug screening when compared to mammalian models. Moreover, due to its transparent nature in early developmental stages and genetic and anatomical similarities with humans, it allows for translatable brain cancer research and related genetic screening and drug discovery. For this reason, the aim of the present review is to highlight the potential of relevant transgenic and xenograft zebrafish models and to compare them to the traditionally used animal models in GBM research.

Advances in glioma therapy and its animal models

Animal Models in Glioblastoma: Use in Biology and Developing Therapeutic Strategies

Advances in glioma models using in vivo electroporation to highjack neurodevelopmental processes

Pre-clinical models for evaluating glioma targeted immunotherapies

Vaccine-based immunotherapy and related preclinical models for glioma

Glioma: experimental models and reality

In vivo C6 glioma models: an update and a guide toward a more effective preclinical evaluation of potential anti-glioblastoma drugs

Highlighting the Zebrafish Xenograft Model

Therapeutics and Research Related to Glioblastoma: Advancements and Future Targets

Advances in computational and translational approaches for malignant glioma

Advances in blood–brain barrier-crossing nanomedicine for anti-glioma

Pharmacological strategies for improving the prognosis of glioblastoma

Glioma targeted therapy: insight into future of molecular approaches

Glioma diagnosis and therapy: Current challenges and nanomaterial-based solutions

Combined-therapeutic strategies synergistically potentiate glioblastoma multiforme treatment via nanotechnology

Emerging therapies for glioblastoma: current state and future directions

Animal models for brain tumors: historical perspectives and future directions

Mouse models of glioblastoma for the evaluation of novel therapeutic strategies

Research Progress in Immunotherapy of Gliomas

Cell-based and cell-free immunotherapies for glioblastoma: current status and future directions

Recent Advances in the Therapeutic Strategies of Glioblastoma Multiforme